A Randomized Controlled Clinical Trial of the GLP-1 Agonist ROSE-010 in Appetite Reduction

被引：0
|
作者：
Kenny, Enda
Mansson, Maria
Samuelson, Per
Hellstrom, Per
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-361
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] GLP-1 Inhibits Prandial Antro-Duodeno-Jejunal Motility in Humans: Native GLP-1 Compared With Analogue ROSE-010 In Vitro
    Halim, Md. Abdul
    Degerblad, Marie
    Webb, Dominic-Luc
    Sundbom, Magnus
    Hellstrom, Per M.
    GASTROENTEROLOGY, 2016, 150 (04) : S97 - S98
  • [2] Mechanism of ROSE-010 Action is Similar to That of GLP-1 and Mediated by the Exendin Receptor: Comparison With GLP-2 and Glucagon
    Hellstrom, Per M.
    Kenny, Enda
    GASTROENTEROLOGY, 2010, 138 (05) : S466 - S466
  • [3] Patient Willingness to use ROSE-010: A Subcutaneous (SC) GLP-1 Analogue for IBS Pain Episodes
    Spiegel, Brennan M.
    Bolus, Roger E.
    Talley, Jennifer
    Chang, Lin
    GASTROENTEROLOGY, 2010, 138 (05) : S227 - S227
  • [4] A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia
    Winzeler, Bettina
    Sailer, Clara O.
    Coynel, David
    Zanchi, Davide
    Vogt, Deborah R.
    Urwyler, Sandrine A.
    Refardt, Julie
    Christ-Crain, Mirjam
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (20):
  • [5] Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics
    Touny, Aya A.
    Kenny, Enda
    Mansson, Maria
    Webb, Dominic-Luc
    Hellstrom, Per M.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (07) : 783 - 791
  • [6] Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Awareness of Hypoglycemia in Type 1 Diabetes: A Randomized Controlled Trial
    van Meijel, Lian A.
    Rooijackers, Hanne M.
    Tack, Cees J.
    de Galan, Bastiaan E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 4143 - 4150
  • [7] Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat
    Hellstrom, P. M.
    Smithson, A.
    Stowell, G.
    Greene, S.
    Kenny, E.
    Damico, C.
    Leone-Bay, A.
    Baughman, R.
    Grant, M.
    Richardson, P.
    REGULATORY PEPTIDES, 2012, 179 (1-3) : 71 - 76
  • [8] Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist
    Young, Malcolm A.
    Wald, Jeffrey A.
    Matthews, Jessica E.
    Scott, Rhona
    Hodge, Rebecca J.
    Zhi, Hui
    Reinhardt, Rickey R.
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 84 - 97
  • [9] GLP-1 Analogs for Therapy of Multiple Sclerosis (MSGLP): Design, Methods and Rationale of Randomized, Controlled Clinical Trial
    Imrich, Richard
    Penesova, Adela
    Vlcek, Miroslav
    Radikova, Zofia
    Havranova, Andrea
    Siarnik, Pavol
    Sivakova, Monika
    Kollar, Branislav
    Turcani, Peter
    NEUROTHERAPEUTICS, 2020, 17 (03) : 1316 - 1316
  • [10] Clinical Trial Highlights ? GLP-1 agonists
    McFarthing, Kevin
    Larson, Danielle
    Simuni, Tanya
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 355 - 368
12345